Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Hematology
Volume 2017, Article ID 3476349, 2 pages
https://doi.org/10.1155/2017/3476349
Case Report

Polycythaemia Secondary to Hormone Replacement Therapy with Tibolone

1Haematology Department, The Canberra Hospital, Canberra, ACT, Australia
2Endocrinology Department, The Canberra Hospital, Canberra, ACT, Australia

Correspondence should be addressed to Philip Young-Ill Choi; moc.liamg@4iohclihp

Received 7 June 2017; Revised 27 July 2017; Accepted 15 August 2017; Published 27 September 2017

Academic Editor: Sudhir Tauro

Copyright © 2017 Laura Staples et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. Bachman, T. G. Travison, S. Basaria et al., “Testosterone induces erythrocytosis via increased erythropoietin and suppressed hepcidin: evidence for a new erythropoietin/hemoglobin set point,” Journals of Gerontology—Series A Biological Sciences and Medical Sciences, vol. 69, no. 6, pp. 725–735, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. S. R. Cummings, B. Ettinger, P. D. Delmas et al., “The effects of tibolone in older postmenopausal women,” New England Journal of Medicine, vol. 359, no. 7, pp. 697–708, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. N. F. Soliman and T. C. Hillard, “Hormone replacement therapy in women with past history of endometriosis,” Climacteric, vol. 9, no. 5, pp. 325–335, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. M. E. De Gooyer, G. H. Deckers, W. G. E. J. Schoonen, H. A. M. Verheul, and H. J. Kloosterboer, “Receptor profiling and endocrine interactions of tibolone,” Steroids, vol. 68, no. 1, pp. 21–30, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. N. H. Bjarnason, K. Bjarnason, J. Haarbo, H. J. T. Coelingh Bennink, and C. Christiansen, “Tibolone: influence on markers of cardiovascular disease,” Journal of Clinical Endocrinology and Metabolism, vol. 82, no. 6, pp. 1752–1756, 1997. View at Publisher · View at Google Scholar · View at Scopus
  6. H. R. Kim, J. H. Lee, and H. R. Heo, “Improved hematopoietic differentiation of human pluripotent stem cells via estrogen receptor signaling pathway,” Cell & Bioscience, vol. 6, article 50, 2016. View at Publisher · View at Google Scholar